Insilica
PrivateLast Round
Grant
Sep 1, 2024
Total Funding Raised
$4.35M
Company Overview
Insilica is a bioinformatics and AI toxicology company that provides a platform and software tools, including Sysrev and ToxIndex, to automate and optimize regulatory-grade chemical safety reports and systematic literature reviews.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Compliance & Risk, Document Management, Healthcare Analytics, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting, Freemium, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Insilica Comparables
Compare Insilica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sciome | 80% | |
| Nested Knowledge, Inc. | 79% | |
| PICO Portal | 78% |
Insilica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2024 | ||||
| Grant | Sep 15, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | May 1, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
Grant | Sep 1, 2020 |
Key People
Founding team and executive leadership
Insilica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| European Commission | Grant |
| National Institute of Environmental Health Sciences | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors increased 82% MoM.
- Nov 17, 2024
Monthly visitors grew 68% MoM.
Recent news
Latest coverage and updates
- integrates_withOct 22, 2026
On Oct 22nd '26 in Maryland and Spain, Insilica Inc integrates with Protoqsar to bring more than 60 ProtoPRED predictive models into ToxIndex for faster, transparent chemical safety assessments, including on-premises deployments.
Insilica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Insilica's valuation, stock price, and market status.
Is Insilica a public or private company?
Insilica is a private company.
What is the current stock price of Insilica?
Insilica is a private company, so its shares have no public market price. Caplight tracks Insilica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Insilica worth (valuation)?
Valuation information for Insilica is not publicly available.
Can I buy Insilica stock?
Insilica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Insilica's last funding round?
Insilica's most recent funding round was Grant on September 1, 2024.
Who are the main investors in Insilica?
Key investors in Insilica include National Institute on Drug Abuse, European Commission, National Institute of Environmental Health Sciences, National Science Foundation.
Will Insilica IPO soon?
No public IPO plans have been announced for Insilica.
How can I track Insilica secondary market activity?
Caplight tracks bids, offers, and trades in Insilica's shares on secondary markets.